[Corrigendum] MicroRNA‑378 enhances migration and invasion in cervical cancer by directly targeting autophagy‑related protein 12.

IF 3.4 3区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
Molecular medicine reports Pub Date : 2025-01-01 Epub Date: 2024-10-18 DOI:10.3892/mmr.2024.13366
Dongmei Tan, Chao Zhou, Sai Han, Xuetao Hou, Shufang Kang, Youzhong Zhang
{"title":"[Corrigendum] MicroRNA‑378 enhances migration and invasion in cervical cancer by directly targeting autophagy‑related protein 12.","authors":"Dongmei Tan, Chao Zhou, Sai Han, Xuetao Hou, Shufang Kang, Youzhong Zhang","doi":"10.3892/mmr.2024.13366","DOIUrl":null,"url":null,"abstract":"<p><p>Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, for the cell migration and invasion assay experiments shown in Fig. 2 on p. 6322, the 'HeLa/miR‑378 inhibitor' panels in Fig. 2B and C appeared to contain overlapping sections of data, such that these data panels were apparently derived from the same original source to show the results of purportedly different experiments. The authors have re‑examined their original data, and realize that Fig. 2C was inadvertently assembled incorrectly. The revised version of Fig. 2, now containing the correct data for the 'HeLa/miR‑378 inhibitor' experiment in Fig. 2C, is shown on the next page. Note that this error did not adversely affect either the results or the overall conclusions reported in this study. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of <i>Molecular Medicine Reports</i> for allowing them the opportunity to publish this. They also wish to apologize to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 17: 6319‑6326, 2018; DOI: 10.3892/mmr.2018.8645].</p>","PeriodicalId":18818,"journal":{"name":"Molecular medicine reports","volume":"31 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11551530/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular medicine reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/mmr.2024.13366","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, for the cell migration and invasion assay experiments shown in Fig. 2 on p. 6322, the 'HeLa/miR‑378 inhibitor' panels in Fig. 2B and C appeared to contain overlapping sections of data, such that these data panels were apparently derived from the same original source to show the results of purportedly different experiments. The authors have re‑examined their original data, and realize that Fig. 2C was inadvertently assembled incorrectly. The revised version of Fig. 2, now containing the correct data for the 'HeLa/miR‑378 inhibitor' experiment in Fig. 2C, is shown on the next page. Note that this error did not adversely affect either the results or the overall conclusions reported in this study. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Molecular Medicine Reports for allowing them the opportunity to publish this. They also wish to apologize to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 17: 6319‑6326, 2018; DOI: 10.3892/mmr.2018.8645].

[更正] MicroRNA-378 通过直接靶向自噬相关蛋白 12 增强宫颈癌的迁移和侵袭。
在上述论文发表后,一位感兴趣的读者提请作者注意,在第 6322 页图 2 中所示的细胞迁移和侵袭实验中,图 2B 和图 C 中的 "HeLa/miR-378 抑制剂 "板块似乎包含了重叠的数据部分,因此这些数据板块显然来自同一原始数据来源,显示了据称不同的实验结果。作者重新检查了他们的原始数据,发现图 2C 是无意中拼接错误的。下一页是图 2 的修订版,现在包含了图 2C 中 "HeLa/miR-378 抑制剂 "实验的正确数据。请注意,这一错误并没有对本研究报告的结果或总体结论产生不利影响。所有作者都同意发表本更正,并感谢《分子医学报告》编辑允许他们有机会发表本更正。他们还希望就给该杂志读者带来的不便表示歉意。[Molecular Medicine Reports 17: 6319-6326, 2018; DOI: 10.3892/mmr.2018.8645]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular medicine reports
Molecular medicine reports 医学-病理学
CiteScore
7.60
自引率
0.00%
发文量
321
审稿时长
1.5 months
期刊介绍: Molecular Medicine Reports is a monthly, peer-reviewed journal available in print and online, that includes studies devoted to molecular medicine, underscoring aspects including pharmacology, pathology, genetics, neurosciences, infectious diseases, molecular cardiology and molecular surgery. In vitro and in vivo studies of experimental model systems pertaining to the mechanisms of a variety of diseases offer researchers the necessary tools and knowledge with which to aid the diagnosis and treatment of human diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信